These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


164 related items for PubMed ID: 2849674

  • 1. Correlation between binding affinities for brain A1 and A2 receptors of adenosine agonists and antagonists and their effects on heart rate and coronary vascular tone.
    Oei HH, Ghai GR, Zoganas HC, Stone GA, Zimmerman MB, Field FP, Williams M.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):882-8. PubMed ID: 2849674
    [Abstract] [Full Text] [Related]

  • 2. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
    Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, Williams M.
    J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
    Bruns RF, Lu GH, Pugsley TA.
    Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
    [Abstract] [Full Text] [Related]

  • 4. A1 and A2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices.
    Churchill PC, Churchill MC.
    J Pharmacol Exp Ther; 1985 Mar; 232(3):589-94. PubMed ID: 2983063
    [Abstract] [Full Text] [Related]

  • 5. Effects of selective A1 and A2 adenosine receptor agonists on cardiovascular tissues.
    Conti A, Monopoli A, Gamba M, Borea PA, Ongini E.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):108-12. PubMed ID: 8377834
    [Abstract] [Full Text] [Related]

  • 6. Affinity chromatography of A1 adenosine receptors of rat brain membranes.
    Nakata H.
    Mol Pharmacol; 1989 Jun; 35(6):780-6. PubMed ID: 2733695
    [Abstract] [Full Text] [Related]

  • 7. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
    Casati C, Monopoli A, Dionisotti S, Zocchi C, Bonizzoni E, Ongini E.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
    [Abstract] [Full Text] [Related]

  • 8. Coronary and myocardial adenosine receptors.
    Schrader J, Kroll K, Henrich M, Piper HM.
    Biomed Biochim Acta; 1987 Mar; 46(8-9):S421-6. PubMed ID: 2829865
    [Abstract] [Full Text] [Related]

  • 9. Adenosine A1 and A2 receptors mediate presynaptic inhibition and postsynaptic excitation in guinea pig submucosal neurons.
    Barajas-Lopez C, Surprenant A, North RA.
    J Pharmacol Exp Ther; 1991 Aug; 258(2):490-5. PubMed ID: 1865352
    [Abstract] [Full Text] [Related]

  • 10. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
    Martin PL, Ueeda M, Olsson RA.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
    [Abstract] [Full Text] [Related]

  • 11. An unusual receptor mediates adenosine-induced SA nodal bradycardia in dogs.
    Belloni FL, Belardinelli L, Halperin C, Hintze TH.
    Am J Physiol; 1989 Jun; 256(6 Pt 2):H1553-64. PubMed ID: 2735429
    [Abstract] [Full Text] [Related]

  • 12. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
    Belardinelli L, Shryock JC, Zhang Y, Scammells PJ, Olsson R, Dennis D, Milner P, Pfister J, Baker SP.
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
    [Abstract] [Full Text] [Related]

  • 13. Antagonism of adenosine-induced relaxation by methylxanthines in coronary artery.
    Ramagopal MV, Rash VA, Mustafa SJ.
    Arch Int Pharmacodyn Ther; 1988 Dec; 295():174-80. PubMed ID: 3245733
    [Abstract] [Full Text] [Related]

  • 14. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S, Ongini E, Zocchi C, Kull B, Arslan G, Fredholm BB.
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [Abstract] [Full Text] [Related]

  • 15. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
    Hutchison AJ, Webb RL, Oei HH, Ghai GR, Zimmerman MB, Williams M.
    J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
    Barrett RJ, May JM, Martin PL, Miller JR.
    J Pharmacol Exp Ther; 1993 Apr; 265(1):227-36. PubMed ID: 8386236
    [Abstract] [Full Text] [Related]

  • 17. Desensitization of adenosine and dopamine receptors in rat brain after treatment with adenosine analogs.
    Porter NM, Radulovacki M, Green RD.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):218-25. PubMed ID: 3335999
    [Abstract] [Full Text] [Related]

  • 18. Negative chronotropic response to adenosine receptor stimulation in rat right atria after run training.
    Priviero F, De Nucci G, Antunes E, Zanesco A.
    Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):741-3. PubMed ID: 15554918
    [Abstract] [Full Text] [Related]

  • 19. Identification of A1 and A2 adenosine receptors in the rat spinal cord.
    Choca JI, Proudfit HK, Green RD.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):905-10. PubMed ID: 3656118
    [Abstract] [Full Text] [Related]

  • 20. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M, Burbiel CE, Müller CE, Knittel J, Verspohl EJ.
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.